Description If you've got a bug (of the bacterial variety), Shionogi & Co. wants to kill it like a shinobi (i.e. ninja) in the night. The Japanese drug firm is a leading maker of antibiotics in its home country, with a full lineup of oral and injectable anti-infectives. It has been expanding its pipeline and its portfolio of marketed products to encompass other therapeutic areas as well, with programs in metabolic conditions and pain management. Through partnerships with large global firms, it owns Japanese market rights to some big name drugs, including AstraZeneca's blood pressure drug Crestor (which Shionogi helped develop), Purdue Pharma's pain therapy OxyContin, and Eli Lilly's depression drug Cymbalta.
Shionogi & Co. has an employee rating of 2.7 out of 5 stars, based on 59 company reviews on Glassdoor which indicates that most employees have an average working experience there. The Shionogi & Co. employee rating is 23% below average for employers within the Pharmaceutical & Biotechnology industry (3.5 stars).
Overall, 30% of employees would recommend working at Shionogi & Co. to a friend. This is based on 61 anonymously submitted reviews on Glassdoor.
38% of job seekers rate their interview experience at Shionogi & Co. as positive. Candidates give an average difficulty score of 2.9 out of 5 (where 5 is the highest level of difficulty) for their job interview at Shionogi & Co..